From the practice record of a random sample of 34 general practitioners (GPs), 340 very old subjects were randomly selected. 261 (77%) agreed to participate. For each subject information on diagnoses and therapies were collected by GPs during an index visit, while thereafter, at home, a social worker administered a structured questionnaire evaluating socio-demographic issues, depressive symptoms (depressive scale from the CARE: CARE-D), daily living activities (ADL and IADL), cognitive status (Mini-Mental State Examination: MMSE) and current use of drugs unreported by the GP. The drugs were coded according to ATC (Anatomic Therapeutic Chemical) clagsification. Unreported drugs were those not declared by GPs when asked to review their patients' pharmacological therapies. Univariate anaiysis was employed to assess the association between unreported drugs and some probable predictors: sex, age, education, living arrangement, use of social services, global judgement by the GP, number of diagnoses and reported drugs, CARE-D, ADL, IADL, MMSE, and marital, working and economic status. Predictors with p_<O.10 at the Z 2 analyses for the associations were included in a multivariate logistic regression.
154 (59%) subjects did not take any unreported drug, 56 (21.5%) took one, 37 (14.2%) two and 14 (5.4%) three or more. The mean number of unreported drugs was 0.7 per subjects, while that of reported ones was 2.8. The univariate analyses identified two statistically significant associations: the first, between high use of unreported drugs and poor education (p=0.0O9), tEe second between high number of unreported drugs and depressive symptoms (p=0.002). An interesting trend for associations was found for age, living arrangement, and MMSE. Multivariate analysis did confirm the statistical and independent significance of education and depressive symptoms as predictors of higher number of unreported drugs.
The most interesting finding is related to the high use of unreported drugs by depressed people, especially because the main class of drugs undetected by the GPs is that of benzodiazepines. Thus, when GPs review drug therapies of their elderly patients, they should pay special attention to subjects with poor education or with depression.
1-Laboratorio di Neuropsichiatria Geriatrica, Istituto di Ricerche Farmacologiche "M.Negri", Milan (italy). 2-Servizio Farmaceutico USSL 1, Turin (Italy).
AGE-DEPENDENT DRUG PRESCRIPTION IN A GENERAL INTERNAL MEDICINE UNIVERSITY OUT-PATIENTS' DEPARTMENT
C. Rougr C.L. Fallab, M. Burnier
Drug comsumption tends to increase with age as elderly patients cumulate several diseases. The multiplicity of drag treatments markedly increases the risk of sideeffects and of potential drug interactions and certainly decreases the patients' compliance to treatment. Teaching of drug prescription is an important task in a universlty-based out-patients' department. Therefore, the purpose of the present study was to evaluate drug prescription in our Medical Policlinic. All the physicians of the medical consultation were asked to fill in a questionnaire at the end of each consultation. The questions concerned the characteristics of the patients, the prescribed drugs and the relevant diagnosis. This questionnaire was applied for one month in summer (June 1992) and another month in winter (February 1993) .
During this two-month period, 3469 consultations were given to 1481 females (43%) and to 1988 males (57%). Overall, 597 patients (17%) were older than 65 years (53% of females and 47% of males). Drugs were prescribed to 2206 patients (64%) witb an a,~erage of 2 ,Imgs per p,-escription Amoqg these patients~ 78% were younger than 65 and 22% were aged 65 or more. Drug prescription was more frequent in elderly (80% of the 597 patients) than in young patients (60%). The number of drugs per prescription averaged 2.4 in old patients and 1.9 in young ones. There was no difference between male and female in either groups
As compared to young patients, elderly patients received essentially more cardiocirculatory drugs including antihypertensive agents (respectively 32.8% of the prescribed drugs in elderly and 8.I% in young) and benzodiazepines (8.3 vs 4.7%). Interestingly, analgesics (NSAID, aspirine and paracetamol) were prescribed more often to young patients (26.3%) than to elderly people (16.8%). Similarly, young patients tend to receive more frequently antibiotics (7.5%) and drugs to treat gastrointestinal diseases (11.3%) than older patients (respectively 2.1% and 6.5%).
Taken together, these results suggest that drug proposal is moderate in a general internal medicine outpatients' department as 37% of the consultations end up with no drag and the average prescription contains only 2 drags. In general, elderly patients are treated with more drugs than their younger counterparts. Elderly receive mainly cardiocirculatm7 drugs, benzodiazepiaes and analgesics whereas in young patients the most prescribed classes of agents are analgesics and drags related to gastrointestinal and cardiocirculatury diseases. The role of the pharmacist in prescription review is well documented 1,2 Pharmacy's evolving mission of providing pharmaceutical care as a means of improving patients' quality of life can be seen as a natural progression of this role. This study aims to identify prescribing indicators which can be used by pharmacists to monitor and improve the quality of patient care.
The medication kardexes of 50 patients were randomly selected from admissions to an acute medical geriatric ward over a 3 -month period. The patients received a daily prescription review by a ward pharmacist. From the medication kardexes the number of doses omitted were determined and the kardex prescriptions were compared to the prescribing guidelines of the British National Formulary 3.
The mean age of the group was 82.3 _+ 6.2 years and the mean length of stay was 15.4 _+ 3.7 days. On average (S,D.), patients were prescribed 7.5 _+ 4.7 drugs per day of which 19.3% were prescribed on an "as required" basis. The mean (S.D.) percentage of doses omitted was 5.6 _+ 7.2% per patient per admission. Furthermore, 14% of patients had been prescribed a sub-therapeutic dosages of medication while 10% had been prescribed dosages which exceeded those recommended. Drugs to be prescribed with caution in the elderly made up 30.2% of the total number of drugs. Twenty-six potential drug interactions were identified in 15 patients. Cardiovascular drugs, diuretics, anticonvutsants and oral hypoglycaemics were among the drugs most commonly implicated.
The data demonstrate the pharmaceutical potential for improving the quality of prescribing in the elderly. Pharrnacists should focus on simple but important interventions; correcting prescribing errors and investigating the omission of therapy. Pharmacists should utitise their expertise to reduce the well recognised, high level of drug-related morbidity in the elderly.
Batty R., Barber N. Ward Pharmacy: a foundation for prescribing audit? Quality in Health Care. 1992;1:5-9.
Hawkey C.J., Hodgson S., Daneshmead T.K., Garner S. The application of psychotropic drugs in elderly patients as such is problematic, since the therapeutic margin of these drugs is smaller in geriatric patients than in younger patients.
The aim of this study is to investigate the use of neuroleptic and antidepressant agents in elderly parkinsonian patients, using the medication surveillance data in computerized systems of community pharmacists, all users of the Pharmacom-system. By involving the prescribing physicians in assessing the criteria used in selecting the neuroleptic and antidepressant agents, the study will provide guidelines for safer administration of these drugs in the management of Parkinson's disease.
Thirty nine community pharmacists are involved in selecting the elderly parkinsonian patients presently using neuroleptics and antidepressants. insomnia 4 Conclusion: Most of the reasons for BZD prescription were insomnia or of organic, psychic or social origin. Neverless, no therapeutic intervention was made to treat pharmacologically or not these primary conditions. Although adaptations to the Formulary were made when patients arrived at the Centre, it was also neccessary to review prescriptions in order to establish wether a drug treatment for insomnia was indicated or not. Other conditions must be considered and treated as origins of insomnia.
* Pharmacy Department. Residencia Asistida de la 3 ~ Edad. Cami dels deposits s/n Carlet, Valencia, Spain.
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DO ELDERLY IN NURSING HOMES USE MORE DRUGS -AND DIFFERENT DRUGS THAN THOSE 1N ORDINARY HOMES OR SHELTERED ACCOMODATIONS?
Claesson CB. Cornelius C. Lindberg J, Thorslund M. Winbl~!0 B, Eight per cent of the Swedish population are 75 years or older. They consume 18 per cent of the medicines prescribed in out-patient care (1).
Few studies have compared the use of medicines in different types of housing, i.e. a persons ordinary home, sheltered accomodation, old-age home, nursing home, geriatric department and hospital ward. Studies that compare the numbcrof medicines used by persons who live in their ordinary home with the number used by those who live in nursing homes or hospital wards, generally find that those who live in their ordinary home use fewer medicines than those in institutions (2, 3, 4).
The aim of this study is to compare the actual use of medicines between elderly in different types of housing i.e. ordinary homes, nursing homes, sheltered accomodations, geriatric departments and hospital wards.
In the present study we used data from the Kungsholmen project. Tiffs project is an ongoing longitudinal study in Stockholm, Sweden. The Kungsholmen Project focuses on medical, psychological, and social problems of aging (5).
Those who live in sheltered accomodations use more medicines than those living in their ordinary homes or in nursing homes. The average number of medicines used by those living in sheltered acconmdations is 4.2 (95% C.I. 3.62-4,76), by those who live in their ordinary home is 3.1 (95% C.I. 2.96-3.22) and in nursing homes 3.2.
There were some differences with respect to the type of medicine that were used in the different types of housing. Significantly more people living in sheltered accomodation than in ordinary homes or nursing homes, used at least one medicine within the ATC group High-ceiling diuretics. The same is true for the ATC group Potassium.In sheltered accomodations more people used at least one medicine within the ATC groups Myocardial therapy (agents acting on) Arteriolar smooth muscle, Low ceiling diuretics, thiazides, Antiinflammatory and antireumatic products, non steroids, Potassium sparing agents and Antithrombotic agents than in nursing homes. A higher proportion of those living in sheltered accomodations used more medicines within tbe ATC goups Laxatives, Opioids, Antipsychotics, Vitamin B12 and folic acid, Expectorants, excl combinations with antituasives and Oral antidiabetics than those living in ordinary homes. The number of patient treatment days of these agents was calculated and used as a basis for discussing their use with senior medical staff. These discussions confirmed inappropriate use and guidelines for the management of constipation, community-acquired pneumonia, uncomplicated urinary tract infections and prevention of thromboembolism following orthopaedic surgery were designed. A booklet containing the guidelines and a strong endorsement from the Medical Director was produced and circulated to all medical staff, wards and pharmacists. The guidelines came into operation on 1st November i992 following a meeting of all medical staff, and pharmacists promoted the guidelines during their ward visits.
The introduction of the guidelines produced favourable results. The number of patient treatment days for a) the 3 months before (May, June, July 1992), b) the 3 months immediately after (November, December, January 1992/3) and c) a subsequent quarter (May, June, July 1993) after the introduction of the guidelines are shown :- The programme resulted in reversing an estimated 30% overspend at October 1992 into a 6% underspend at the end of the financial year 1992/3 compared with the corresponding periods in 1991/2. The study indicates that pharmacists and medical staff are able to work together to improve prescribing on a care of the elderly unit.
Medicines Research Unit, Welsh School of Pharmacy, University of Wales, Cardiff, UK. CF1 3XF and Cardiff Royal Infirmary, Newport Road, Cardiff, UK. CF2 1SZ
IMPROVEMENT OF TREATMENT OBSERVANCE :AN EXPERIMENT OF CLINICAL PHARMACY COUNSELLING TO THE ELDERLY
A. Le Duiqou, O. Garoche, P Jahier, C. Cattenoz. P. Sado, D Delamaire latrogenic pathology is more frequent in the elderly for a variety of reasons : polypathology resulting in polymedication, favouring drug interactions, age-related pharmacokinetic and pharmacodynamic modifications, and also patients' misunderstanding of the treatments, source of multiple errors.
With the help of pharmacy students, a protocol of clinical pharmacy counselling was instated in the geriatrics department of the Rennes Teaching Hospital.
Aims : to promote drug observance and prevent possible errors, by improving the elderly's awareness, as well as their familiars', to their treatments.
Method : any elderly person dismissed from the mid-term stay ward to return home had an interview with a non-resident student pharmacist, to assess their awareness to their previous treatment, and provide verbal and written counselling and information by means of a clear and simple table explaining the new treatment. The family physicians, informed of the protocol, were contacted later for their opinion.
Results : over a 3-month period and in 110 dismissals, 45 eldedy subjects were given pharmacy counselling. Sixty-four per cent were taking their treatment by themselves, although 50% did not know the name or the indications of any of their drugs, and 25% recognized them only from their aspect. Thirty-eight of 45 elderly subjects were given a table explaining their new treatment. Twenty-one of 37 family physicians expressed an extremely favourable opinion, after observing true benefit in 30 elderly subjects. In the other 8 patients, the protocol proved ineffective due to their lack of interest, habituaJ undiscipline, or psychical impairment.
Conclusion : The benefit observed to the elderly encourages the authors to continue the pharmacy counselling action, within a new protocol aimed at assessing the actual impact on patients by a work-up to be performed at home after one month, and by interviewing the family physicians and pharmacists. The cost of the discharge medication in the group, using hospital prices, was calculated as a percentage of the total drug bill per patient. On average (range) each patient's discharge medication represented 35 % ( 1 -99%) of the total drug bill.
In conclusion, in the elderly, the total drug cost represents a small fraction of the total admission cost for the hospital. Discharge medication made up 35% of total drug cost in this sample, indicating that a policy of shorter hospital stay may increase drug costs. #C. Flora& #A. de Boer, * # A. van Didk, ~4 .~ Porsius Drug-related hospital admissions are caused by several factors such as intoxications, undertreatment (drug non-compliance and inappropiate drug choice) and side effects of drugs which are in part unavoidable, in part avoidable e.g. because of drug interactions and use of contraindicated drugs. Lack of comprehensive information among the physicians about all the drugs used by a patient is also a contributing factor which merits further investigation. In the D-TOPIC (Drug Therapy Of Patients In Clinics) study some of these problems are investigated by studying the qualiw of drug therapy in patients before, during and after hospitalization. Main questions are the occurrence and extent of drug related hospital admissions and the relation of the quality of drug therapy with these hospital admissions. Furthermore, in a randomized trial standard medical care is compared with an intervention based on a discussion of quality of pharmacotherapy by a pharmacist with the attending phycisian in addition to medical care. Here we report on the pilot study.
Thirty-four patients (59% women, mean age 67 (range: 34-86)) admitted to the general ward of an acute care hospital were included in the study after obtaining informed consent. An interview emphasizing the drugs used before hospitalization was conducted. Relevant medical data were extracted from the medical notes. Pharmacy records and additional medical data were collected from the community pharmacists and the general practitioners, respectively. Data were entered in and analysed with a computerised database. Quality of medication was assessed using a method proposed by our group. Suboptimal drug use was allocated to one of the following categories: choice of drugs, dosage, overprescription, (pseudo)double-medication, drug interactions or contraindications. Severity of suboptimai drug use is indicated by two grades: grade I is given when medication is considered inappropriate or unnecessary dangerous; grade II is given when the medication is suboptimal, but risks are probably Iow.
Most common reasons for hospital admission were gastro-intestinal problems (30%) and poor control of diabetes mellitus (15%). Suboptimal drug therapy of grade I and grade [I was scored 12 and 29 times, mspectively. One hospital admission was probably drug related. Although 172 drugs should have been used according to the pharmacy records data, only t27 drugs were reported by the patients. Non-compliance of drug use was seldom reported (6%). The effectiveness of a drug was reported to be good in 63%.The response of general phycisians to requests for information was Iow (50%). In contrast, the response of the community pharmacists was 100%.
There is a considerable discrepancy between the nun'lber of drugs used as reported by patients admitted to a general ward compared to pharmacy records. As a result of the pilot study several modifications to the study protocol were made. Objectives: Analysis of the use of antiinfectives (antibiotics, antivirals, antifungals) in geriatric in-patients between 1983 and 1992: drug classes, total costs, length of treatments.
Method and patients:
Retrospective study of annual use of systemic antiinfective drugs in two geriatric university hospitals of 410 beds, with a patient mean age of 83 years and a male/female ratio of 1:3. During the study period, the number of patient admissions per year went up from 2206 to 2917 and the mean length of stay decreased from 56 to 51 days. Consequently the number of hospital days increased from 136'000 to 146'325,
Results and discussion: 1) General changes between 1983 and 1992:
-the percentage of systemic antiinfective drugs increased from 16 to 36% of total drug expenditure. Costs for all drugs increased by 93% and for antibiotics by 331% (Consumers' price index: +33%) -the number of antiinfective treatment days, calculated as recommended by the WHO, increased from .13 to 27 Prescribed Daily Dose (PPD) per 100 days; -the mean cost of antiinfective treatment increased from 4.80 to 9.60 SFR/day during the period under study. The ratio of parenteral vs. oral treatment changed from: 55% / 45% to 63% / 37% for cost, and from 13% / 87% to 16% / 84% for PDD.
2) Comparison of antibiotic categories between 1983 and 1992: -Penicillin
uses were constant in number of treatement days (ca. 40% of all antibiotics). Their cost decreased from 47% to 28% in 1992.
-Cephalosporins
(including Imipenem/cilastatin) represented only 5 to 10% of PDD, but their cost increased from 20% in 1983 to 37 % m 1992. -Sulfonamides PDD decreased from 21% (1983) to 7% (1992) and their percentage in costs from 9 % to only 1% in 1992.
-QuiI:olones represented just 2% of PDD in 1983 and 31% in 1992, contributing to 19% of total costs in 1992.
-Aminoglycosides lost some of their importance: 14% of costs for 3% of PDD in 1983 and less than 1% of treatment days, and 1% of antiinfective costs in 1992.
-Maerolides (including Clindamycin, Vancomycin and Teicoplanin), show a decrease in PDD (8% vs. 3%), but an increase in costs (3% vs. 9%); newer, more expensive injectable drugs, replacing oral macrolides, explain this fact.
Conclusions:
These results allow us to look for explanations and to make recommendations: -a higher number of admissions and turnover of patients can explain a part of the increased drug use per patient and per hospital day; -the strong pressure for using Ore newest drugs must be resisted; -restriction of antibiotic use through a drug fornmlary has been quite effective, but development of resistant pathogens may necessitate the introduction of newer, more expensive antibiotics; -the clinical pharmacist has an important role to play by * limiting access to new antiinfective drugs and admit them only if they are clearly superior to older drugs; * fixing strict criteria for the use of parenteral treatments, and favouring a rapid switch from injectable to oral drugs.
Institutions universitaires de gdriatrie, Pharmacy service, CH-1226 Tht)nex/Switzerland

REPORT FIVE CASES OF BRADYARRHYTHMIAS ASSOCIATED WITH THE BETA-BLOCKERS EYE-DROPS IN ELDERLY PATIENTS.
Aumente MD*, Panadero MD, Segura jl An~uita M ~, Alvarez I.
The elderly population are the main medication users. The changes that bring about norinal aging processes wiI1 alter the answer to the drugs, increasing the incidence of adverse reactions to drugs (ADRs) and therapeutic failure. The incidence of ADRs is found among 4.5-15% for patients over sixty; 8.2-21.9% over seventy and 24% over eighty.
Five cases of symtomatic bradycardia due to topical ocular Beta-blockers administration (four cases for timolol and the other one for carteolol) in elderly patients without heart disease are reported. Two patients had syncope-related to atrioventricular block, and the other three patients complained of dizziness due to sinus bradycardia. Heart disease was not present in any case, although a right bundle branch block was observed in one patient. A normal sinus rhythm resumed in all patients after discontinuation of eye-drops.
It is impotant to emphasize that all cases were over sixty; It is Known that the elderly patients are more sensitive to beta-blockers, so it seems to happen through topical administration.
In conclusion, the use of beta-blockers as the timolot and carteolol by topical ocular administration can produce slow accidental changes of the rhythm with important symptoms in elderly patients.
Pharmacy and Cardiology ~ Departments, Hospital Universitario Reina Sofia, C/Avda Menendez Pidal s/n, 14004-C6rdoba (Spain). 
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METHOD:
This study was carried out on admission of 250 patients during a period between 10.5 -15.7.1993 to a geriatric university hospital containing 300 beds. A blood test including the dosage of potassium, sodium, glucose and creatinine was carried out for each patient. The drugs and diseases present on admission to the hospital were registered on the admission form of the patient.
SUBJECTS:
The age of the patients ranged between 62 and 104 years (average: 84). The patients weight varied between 25 and 131 Kg (average: 60). Male/female ratio: 32%/68%. A significant increase of kaliaemia was observed in diabetic patients (14% of the patients), in patients on spironolactone (4%), on heparin (4%) and in patients suffering fronl acidosis (1%). A significant decrease of kaliaemia was observed in patients receiving thiazides (18%), acetazolamide (1%) and corticosteroids (4%). We observed no significant variation of kaliaemia in patients on NSAIDs (31%), ACE (12%), amiloride (5%), g-blockers (4%), a-stimulants (2%), stimulant laxatives (8%), loop diuretics (18%), L-Dopa (6%), nifedipine (6%) and inhaled g2-stimulants. (2%). A significant correlation is observed between kaliaemia and natraemia, kaliaemia and plasmatic creatinine, and kaliaemia and the creatinine clearance.
CONCLUSION:
Electrolyte disturbances represent a frequent metabolic pathology in geriatric patients. Their causes are often multifactorial but there are clear indications that the drugs prescribed play a major role and our study indicates these parameters should be regulary controlled when diuretics, corticosteroids and heparin are prescibed to this age group. One hundred and seventy-two elderly patients with Chronic Obstructive Airway Disease requiring theophylline therapy were included in the study. They were distributed in 4 groups: I-Patients without any known factor afecting the theophylline kinetics (n=75). II-Patients under treatment of Congestive Heart Failure (CHF) (11=76).
IlI-Smokers (n= 12). IV-Smokers with CHF (n=9).
Individual pharmacokinetic parameters were calculated from two steady-state theophylline levels obtained in the elimination phase.
The mean pharmacokinetie parameters were: Based on these results, we conclude that theophylline requirements are lower in non-smoker elderly patients than in adults.
Smoker elderly patients had higher theophylline requirements than non-smoker adults. This requirements decreased when both tobacco and CHF were present.
Although patients with CHF had the longest theophylline t *A, their theophylline clearance and dose requirements were not lower than in the other groups. The high Vd estimated for these patients would explain this fact.
Pharmacy Department. Fundacidn Matin. San Sebasti~in. Spain. ** Pharmacy Department. Hospital Sant Pan. Barcelona. Spain.
PHENYTOIN KINETICS IN THE ELDERLY : HOSPITALIZED PATIENTS TREATED WITH AN I.V. LOADING REGIMEN FOLLOWED BY INDIVIDUAL DOSAGE BASED ON BAYESIAN FORECASTING CALCULATIONS
E. Martinclli*, S. Mtihlebach, S. Vozeh#
Phenytoin still represents a mainstay in the treatment of epitepsia and has shown its therapeutic value to prevent posttraamatic seizures in patients andergoing cerebral surgery or presenting acute cerebral disorders after aneurisms trauma etc. I. To reach efficient therapeutic concentrations as soon as possible the use of an i.v. loading regimen and serum level monitoring is mandatory. Serum concentmtinns of 10 -20 mg/L represent a generally accepted therapentic range but individualization of dose is necessary because of the small therapentic index, the nonlinear pharmacokinetics with varying individual pharmacokinetic parameters (Vmax, Kin) , and the drug interaction potential of phenytoin. To evaluate the usefulness of a fixed i.v. loading regimen with dose adaptation after 5 days in hospitalized patients, non-steady state phenytoin trough levels were used to calculate individual doses by numerical integration of MichaelisMenten formula and Bayesian forecasting. Steady State concentrations are only reached within about 3 weeks of treatment. A special emphasis was given to detect possible kinetic differences between younger and older adidt patients. A total of 68 patients with a mean age of 49.7 • 15.2 years were evaluated. Out of them 15 patients were 65 or more 3vars old (71.9 + 4.2 years). No exclusion of patients was made for potentially interfering co-medications. The standard first loading dose consisted of 15 mg/kg body weight infused over 4 hours, followed by 175 tug and 200 mg i.v. every 12 hours for patients up to 70 kg and > 70 kg respectively. Three serum trough levels were determined: just before the second dose and prior to the morning doses of day 4 and 5. For individual dosage calculation a target level of 11 mg/L was chosen. In this study no significant kinetic differences for phcnytoin could be detected in the cldcrly. 80% of all patients showed a plasma level of 10 -20 mg/L after the first dose interval. At day' 5 still 80% of the elderly patients were within this conec'ntratioa range (65% for the whole group). About 85% of patients required a dose adaptation on day 5 (dose range between 100 and 650 mg per day). The semm level prediction (at 212 _+ 38 hours after the start of therapy) showed equal accuracy in both groups. Without adaptation the steady state levels of about 70% of total and of ederly patients would be outside the therapeutic range most of them above 20 mg/L. Therefore only calculation programs able to use non-steady state levels are reliable for dose adaptation during initial therapy. The results demonstrate that the proposed i.v. loading regimen over 5 days is effective to reach rapidly therapeutic levels of phenytoin and to maintain them throughout this period in the vast majority of hospital patients needing such a therapy. In absence of sxeady state conditions the calculation program used is suitable for dose individualization requested after 5 days and the follow-up of therapy. Although the number of elderly patients was not large, the results clearly indicate that no significant differences in the phenytoin levels of the elderly are to be expected druing acure dosing assuming no relevant age-related mecbmtisms of pharmacokinetics.
1 Temkin N.R., Dimken S.S., Wilensky AJ., Keihm J., Chabal S., Winn H.R. Digoxin (DGX) is one of the most commonly p,:escribed drugs in eldery patients in our country. Because of its narrow therapeutic range and important interindividual variability in drug disposition, it is necessary to individualize the DGX dosage. The aim of the present study was to assess the prescription pattern and control of DGX treatment in eldery patients, admitted to the general medical wards in our hospital, and compare it to a previous DGX utilization study carried out by our team in I989 (1). The 1989 DGX utilization study prompted us to establish a new clinical pharmacy strategy to monitor all eldery patients on DGX admitted to the general medicine wards. All patients, aged _> 65 years on DGX treatment from May first to October 31st of 1993 were retrospectively included in this study. A data collection form was used to record age, sex, weight of the patient, reason for DGX prescription, reason for admission, medical assessment of DGX compliance, DGX plasma levels, loading and maintenance DGX dose, serum urea, creatinine and electrolytes, concomitant drugs and length of hospitalization. During the study period we followed twenty seven DGX treatments administered to twenty six patients (21 females). Their mean age was 78,5 _+ 6,8 years. Patient weight was recorded in 85 % (n=23) of the cases. Atrial fibrilation with fast ventricular rate was the main indication for DGX treatment (63%) (n= 17). A DGX loading dose (0,5 -1 rag) was given to 8 patients (30%) without previous treatment. Most patients (77 %) were already under DGX treatment at admission. The differences between the 1989 and 1993 DGX utilization studies are shown in the following The'new strategy to monitor DGX in our hospital has produced a dramatic improvement in its dosage and treatment control. An increase in the percentage of monitored patients (from 72 to 96%) has permitted us to safely vary the standard DGX doses (only 23% of patients received standard doses) and significantly reduce the number of patients under toxic (from I9,4 to 3,7 %) or subtherapeutic levels. Moreover, control of DGX treatment reduced from I6,6 % to zero the instances in which clinical toxicity was recorded due to its interaction with concomitantly administered drugs. It is well known that deficiencies in vitamin BI2 and in folic acid have the same capacity to produce megaloblastic anemia in Humans. However,while the neuropathological disorders caused by lack of vitamin BI2 are well established,it has been commonly believed that folate deficiency is not associated with any abnormality in the central nervous system. In addition,pure folate deficiency in adults is almost nonexistent. This view has recently been challenged and there is increasing evidence relating various neurological syndromes to folic acid deficiency. In a previous study we have showed that in elderly the blood folate levels are generally decreased. In the present study we have studied the psychological profile, before and after treatment by oral folinic acid, of people above 60 years old who have folate deficiency established by levels under 200 ng/ml in red blood cells.
Patients (n=67; age 67 +/-5 years) were included in the study when erythrocyte folate levels determined by radioimmunoassay were lower than 200 ng/ml. Criteria for exclusion were presence of megaloblastio anemia and presence of organic diseases (MMS,DSM III). Psychological profiles were studied by means of Zung scales of depression and anxiety and a serie of 16 tests including PRM from Rey,Benton's VRT,3 words of Luria,Porteus maze,reaction time test,daily activity test,compound series of Morisby... These series of test were passed at day 0 and at day 120 after treatment by folinic acid (50 mg/week by oral route).
The level of erythrocyte folates is significantly increased from 163+/-11 to 355 +/-17 and the score of the depressive Zung scale is slightly but significantly decreased from 65 +/-5 to 51 +/-4 (threshold of depressive disease 56).
A relationship is observed between folate deficiency and decrease in learning,memory abilities,concentration and vigilance capacities .The most specific symptoms are the deterioration of associative memory and a disrupture of spatio-temporal organisation. After treatment,these symptoms are suppressed and the patients have interest in live.
Introduction
-Urinary tract infections (UTI) in geriatric patients are common and increase with age and functional disability. Microbiological identification of this type of infections is relatively easy to perform, as well as the antibiograms.This allows us to have a follow-up of the predominant pathogens and the resistance developpmnent to antibiotics.
Objectives -To adapt the treatment recommandations and to take preventive mesures in regard of the resistance developpement of the bacteria identified in our population, based on a regular follow-up of the UTL Subjects -Inpatients in a geriatric university hospital of 320 beds with a mean age of 83 and a male/female ratio of approximatively 1 to 3. The mean length of stay is about 45 days.
Method . Every 3 years since 1986 (1986, 1989 and 1992) and during a 3 months period (15.6. -15.9) all the antibiograms made for UTI in our hospital were collected and analysed for the prevalance of the pathogens and their resistance to currently used antibiotics.
Results -The number of bacterial pathogens identified is degressive since 1986, even though the number of patient admissions has increased in the same period. The proportion between Gram-and Gram+ bacteria is the same in 1989 and 1992 (about 70% to 30%), but different, compaired to I986, when the ratio was 60 ] 40 %. 9 Gram-pathogens: E. coli remained the main pathogen at the origin of UTI during the whole observation period (between 39 and 45% of all identified). The number of UTI due to P. aeruginosa which increased significantly from 1986 to 1989 was proportionaly less important in 1992. There was a slight increase of Klebsiella spp. in 1992, but Psychotropic drug use has been widely studied and discussed, however, few studies have focused on factors associated with psychotropics among the elderly. The aim of this study was to analyse the relationship between sociodemographic factors, socioeconomy, social network, different health variables, physician visits and the use of psychotropie drugs among elderly home dwellers.
The study area was the municipality of Tierp, located in mideastern Sweden, which has a population of about 21,000 inhabitants. In 1986, all non-institutionalized persons aged 85 years and older and a random sample of those 75-84 years (N=421) were interviewed by district nurses The nurses also made health assessments of the elderly. These data were linked to a computerized research register of health care utilization and prescription drug purchases. Multivariate analyses were performed using the LISREL 8 statistical software program.
In the multivariate analyses, four factors turned out to be associated with psychotropic drug use among the elderly. The strongest relationship was found between assessed mental health and psychotropic use, followed by loneliness, physician visits and assessed physical health.
Three out of four factors related to psychotropic drug use among the elderly were health related, which show that users have a poorer health than non-users. A factor to consider is the extensive use of psychotropics among the elderly. Further studies are therefore needed to analyse to what extent the prescribing is motivated by a poorer health and how much is prescribed in a routine fashion way. Aim: The aim of the project is to optimize the medication of the residents by involving the pharmacist and her drug expertice in the medication in collaboration with doctors and nursing staff.
Material and methods: We wanted to achieve this aim through the establishment of Consulting Pharmacy offering the following to nursing homes: medication surveillance for every resident, including recommendations to doctor and nurse about the medcation training in medication of nursing staff instruction in drugs of nursing staff surveillance of the stock of drugs recommendations concerning analyses advice on drugs for the nursing home Five pharmacists have acted as Consultant Pharmacist to different nursing homes during one year. The evaluation of the effects was made by means of: statement of registered medication surveys for the residents questionnaire to health care professionals changes in drug expenses for the residents and for the nursing homes monthly reports to the nursing homes minutes of meetings
Results: By the end of the project the residents were well medicated. The number of drugs per resident had not decreased but the use of psychoactive drugs had diminished. There was a positive approach to the pharmaceutical service, especially from the nursing staff. Consulting Pharmacy has resulted in savings on medicine expenses. It is recommended to others to take up the activity and a "package" will be launched for others to use when starting up Consulting Pharmacy. Following review of the clinical elective course in the final year of the B.Pharm III degree at the Welsh School of Pharmacy, Cardiff, a Pharmaceutical Care of the Elderly module was introduced. The module aims to introduce students to the pharmaceutical problems encountered by the elderly and consists of six 3 hour sessions; aspects of aging, caring for the elderly, adverse drug reactions in the elderly, individualisation of drug therapy for the elderly, compliance and total patient care.
The emphasis of teaching is on the use of workshops and self study. Problems are presented as case studies and videos from which the students work in small groups to determine patient management plans. For example, in the Total patient care session a patient is presented on video and the students develop a pharmaceutical management plan which includes compliance aspects and the role of the pharmacist, in addition to solving therapeutic problems.
At the end of the first module, 25 of the 27 students who took the module completed an evaluation which consisted of a general appraisal, sessional appraisals and general comments. Twenty-one students (84%) agreed or strongly agreed that the module was interesting and that the module made them think around the subject. The students were asked to rate the content, presentation and relevance of the six sessions on a scale of 1 to 5 where 1 = extremely poor and 5 = very good. Favourable results were obtained. For example, a rating of 4 or 5 was given by I5 students (60%) for presentation, 18 students (72%) for content and 24 students (96%) for relevance of the session on adverse drug reactions in the elderly. Comments received from the appraisals were used to make minor adjustments for the future development of the module.
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